The potential immunogenicity of GFP in mice was first reported by Stripecke et al (1999) who found that stable expression of EGFP in two mouse tumours inhibited tumour growth and led to formation of cytotoxic CD8 T cells that recognise EGFP-expressing cells. The gene discussed is CD8A; the disease is neoplasm.